305 research outputs found
Land planarians (Platyhelminthes) also prey on web-building spiders
Although spiders and land planarians constitute diverse groups of terrestrial predators, interactions between them are still unknown. Here, we describe a predatory event of a land planarian (Choeradoplana cf. gladismariae) on a web-building spider (Helvibis longicauda) in the Brazilian Atlantic Forest. The prey was constricted and covered with sticky mucus while remaining on its web trying to protect its egg sac. The event was observed in the middle-end afternoon at ca. 1.80 m height. Our observation broadens the scope of possible natural enemies of web-building spiders and the prey items of land planarians. It also indicates that these organisms can capture and overpower dangerous predatory arthropods, suggesting that even complex three-dimensional sticky webs can be ineffective against the attack of land planarians. Finally, we also show that land planarians can exhibit a flexible foraging strategy, exploiting the environment during the day and at higher heights from the ground. Our observation opens new possibilities involving focal observations and experiments using spiders and land planarians as models in predator-prey research
Identification of prefoldin amplification (1q23.3-q24.1) in bladder cancer using comparative genomic hybridization (CGH) arrays of urinary DNA
Array-CGH represents a comprehensive tool to discover genomic disease alterations that could
potentially be applied to body fluids. In this report, we aimed at applying array-CGH to urinary samples to
characterize bladder cancer.
Methods: Urinary DNA from bladder cancer patients and controls were hybridized on 44K oligonucleotide arrays.
Validation analyses of identified regions and candidates included fluorescent in situ hybridization (FISH) and
immunohistochemistry in an independent set of bladder tumors spotted on custom-made tissue arrays (n = 181).
Results: Quality control of array-CGH provided high reproducibility in dilution experiments and when comparing
reference pools. The most frequent genomic alterations (minimal recurrent regions) among bladder cancer urinary
specimens included gains at 1q and 5p, and losses at 10p and 11p. Supervised hierarchical clustering identified the
gain at 1q23.3-q24.1 significantly correlated to stage (p = 0.011), and grade (p = 0.002). The amplification and
overexpression of Prefoldin (PFND2), a selected candidate mapping to 1q23.3-q24.1, correlated to increasing
stage and tumor grade by means of custom-designed and optimized FISH (p = 0.013 and p = 0.023,
respectively), and immunohistochemistry (p ≤0.0005 and p = 0.011, respectively), in an independent set of
bladder tumors included in tissue arrays. Moreover, PFND2 overexpression was significantly associated with poor
disease-specific survival (p ≤0.0005). PFND2 was amplified and overexpressed in bladder tumors belonging to
patients providing urinary specimens where 1q23.3q24.1 amplification was detected by array-CGH.
Conclusions: Genomic profiles of urinary DNA mirrowed bladder tumors. Molecular profiling of urinary DNA
using array-CGH contributed to further characterize genomic alterations involved in bladder cancer progression.
PFND2 was identified as a tumor stratification and clinical outcome prognostic biomarker for bladder cancer
patientsSupported by grants (SAF2009-13035 and SAF2012-40206) from the Spanish
Ministry of Education and Culture (to Dr Sánchez-Carbayo). Virginia López is
recipient of a predoctoral award from the Spanish Ministry of Education and
Cultur
Non-emissive RuII Polypyridyl Complexes as Efficient and Selective Photosensitizers for the Photooxidation of Benzylamines
RTI2018-100709-B-C21 CTQ (QMC)-RED2018-102471-T) Junta de Castilla y Leon (BU087G19 FEDER (BU042U16-BU305P18).Five new RuII polypyridyl complexes bearing N-(arylsulfonyl)-8-amidoquinolate ligands and three of their biscyclometalated IrIII congeners have been prepared and employed as photocatalysts (PCs) in the photooxidation of benzylamines with O2. In particular, the new RuII complexes do not exhibit photoluminescence, rather they harvest visible light efficiently and are very stable in solution under irradiation with blue light. Their non-emissive behavior has been related to the low electrochemical energy gaps and rationalized on the basis of theoretical calculations (DFT analysis) that predict low S0←T1 energy values. Moreover, the RuII complexes, despite being non-emissive, display excellent activities in the selective photocatalytic transformation of benzylamines into the corresponding imines. The presence of an electron-withdrawing group (-CF3) on the arene ring of the N-(arylsulfonyl)-8-amidoquinolate ligand improves the photocatalytic activity of the corresponding photocatalyst. Furthermore, all the experimental evidence, including transient absorption spectroscopy measurements suggest that singlet oxygen is the actual oxidant. The IrIII analogues are considerably more photosensitive and consequently less efficient photosensitizers (PSs).authorsversionpublishe
Recommended from our members
Impaired Prefrontal Synaptic Gain in People with Psychosis and Their Relatives during the Mismatch Negativity
The mismatch negativity (MMN) evoked potential, a preattentive brain response to a discriminable change in auditory stimulation, is significantly reduced in psychosis. Glutamatergic theories of psychosis propose that hypofunction of NMDA receptors (on pyramidal cells and inhibitory interneurons) causes a loss of synaptic gain control. We measured changes in neuronal effective connectivity underlying the MMN using dynamic causal modeling (DCM), where the gain (excitability) of superficial pyramidal cells is explicitly parameterised. EEG data were obtained during a MMN task—for 24 patients with psychosis, 25 of their first‐degree unaffected relatives, and 35 controls—and DCM was used to estimate the excitability (modeled as self‐inhibition) of (source‐specific) superficial pyramidal populations. The MMN sources, based on previous research, included primary and secondary auditory cortices, and the right inferior frontal gyrus. Both patients with psychosis and unaffected relatives (to a lesser degree) showed increased excitability in right inferior frontal gyrus across task conditions, compared to controls. Furthermore, in the same region, both patients and their relatives showed a reversal of the normal response to deviant stimuli; that is, a decrease in excitability in comparison to standard conditions. Our results suggest that psychosis and genetic risk for the illness are associated with both context‐dependent (condition‐specific) and context‐independent abnormalities of the excitability of superficial pyramidal cell populations in the MMN paradigm. These abnormalities could relate to NMDA receptor hypofunction on both pyramidal cells and inhibitory interneurons, and appear to be linked to the genetic aetiology of the illness, thereby constituting potential endophenotypes for psychosis
Identification of DNA hypermethylation of SOX9 in association with bladder cancer progression using CpG microarrays
CpG island arrays represent a high-throughput epigenomic discovery platform to identify global disease-specific promoter hypermethylation candidates along bladder cancer progression. DNA obtained from 10 pairs of invasive bladder tumours were profiled vs their respective normal urothelium using differential methylation hybridisation on custom-made CpG arrays (n=12 288 clones). Promoter hypermethylation of 84 clones was simultaneously shown in at least 70% of the tumours. SOX9 was selected for further validation by bisulphite genomic sequencing and methylation-specific polymerase chain reaction in bladder cancer cells (n=11) and primary bladder tumours (n=101). Hypermethylation was observed in bladder cancer cells and associated with lack of gene expression, being restored in vitro by a demethylating agent. In primary bladder tumours, SOX9 hypermethylation was present in 56.4% of the cases. Moreover, SOX9 hypermethylation was significantly associated with tumour grade and overall survival. Thus, this high-throughput epigenomic strategy has served to identify novel hypermethylated candidates in bladder cancer. In vitro analyses supported the role of methylation in silencing SOX9 gene. The association of SOX9 hypermethylation with tumour progression and clinical outcome suggests its relevant clinical implications at stratifying patients affected with bladder cancer
On dynamic network entropy in cancer
The cellular phenotype is described by a complex network of molecular
interactions. Elucidating network properties that distinguish disease from the
healthy cellular state is therefore of critical importance for gaining
systems-level insights into disease mechanisms and ultimately for developing
improved therapies. By integrating gene expression data with a protein
interaction network to induce a stochastic dynamics on the network, we here
demonstrate that cancer cells are characterised by an increase in the dynamic
network entropy, compared to cells of normal physiology. Using a fundamental
relation between the macroscopic resilience of a dynamical system and the
uncertainty (entropy) in the underlying microscopic processes, we argue that
cancer cells will be more robust to random gene perturbations. In addition, we
formally demonstrate that gene expression differences between normal and cancer
tissue are anticorrelated with local dynamic entropy changes, thus providing a
systemic link between gene expression changes at the nodes and their local
network dynamics. In particular, we also find that genes which drive
cell-proliferation in cancer cells and which often encode oncogenes are
associated with reductions in the dynamic network entropy. In summary, our
results support the view that the observed increased robustness of cancer cells
to perturbation and therapy may be due to an increase in the dynamic network
entropy that allows cells to adapt to the new cellular stresses. Conversely,
genes that exhibit local flux entropy decreases in cancer may render cancer
cells more susceptible to targeted intervention and may therefore represent
promising drug targets.Comment: 10 pages, 3 figures, 4 tables. Submitte
- …